肝切除术后联合肝动脉化疗栓塞综合治疗大肝癌中长期生存率

Long Term Survival Rate of Liver Resection Combined with TACE Comprehensive Treatment in Large Hepatocellular Cancer Patients

目的:探讨大肝癌病人肝切除术后和肝切除术后联合肝动脉化疗栓塞(TACE)综合治疗大肝癌中长期生存率。方法:回顾性分析360例肝细胞癌病人本院行肝切除术后的长期疗效及生存状况,其中进行单纯手术治疗185例,手术联合TACE综合治疗组175例。结果:肝癌病人单纯手术治疗1、3、5年生存率分别为71.7%、59.3%、35.7%,术后联合TACE综合治疗1、3、5年生存率分别为82.5%、71.3%、56.7%。结论:手术联合TACE综合治疗方案对于大肝癌病人具有更好的治疗效果,在提高患者远期生存状况方面更优。

Objective：To investigate survival rate of patients with large hepatocellular carcinoma（HCC）after liver resection and liver resection combined with TACE comprehensive treatment.Methods：A retrospective analysis was performed on long-term curative effect after hepatic resection and survival status of 360 cases of HCC patients,of who,185 cases in surgery group,and 175 cases of surgery combined with TACE treatment group.Results：In surgery group,1,3,5years survival rate were 71.7%,59.3%,35.7%,while in TACE combined with surgery group 1,3,5years survival rate were 82.5%,71.3%,56.7%.Conclusion：Postoperative TACE combined with surgery treatment for patients with large HCC has better therapeutic effect,better in improving the long-term survival.